Evidence map›Paper›PMID 28846555›Full record

ArticleTransplantation2018

Swine Leukocyte Antigen Class II Is a Xenoantigen.

Joseph M Ladowski, Luz M Reyes, Gregory R Martens, James R Butler, Zheng-Yu Wang, Devin E Eckhoff, Matthew Tector, A Joseph Tector

Open access · greenAbstract read
In one paragraph

Article in Transplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 96 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Immunometabolism of Liver Xenotransplantation and Prospective Solutions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Pig Xenotransplantation in Beta Cell Replacement: Addressing Challenges and Harnessing Potential for Type 1 Diabetes Therapy.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  13. The Evolution of Immunosuppressive Therapy in Pig-to-Nonhuman Primate Organ Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  14. Article
  15. Shooting for the moon: Genome editing for pig heart xenotransplantation.The Journal of thoracic and cardiovascular surgery · 2023
    Article
  16. Article
  17. Xenorecognition and costimulation of porcine endothelium-derived extracellular vesicles in initiating human porcine-specific T cell immune responses.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  18. Milestones on the path to clinical pig organ xenotransplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Review
  19. Review
  20. Developments in kidney xenotransplantation.Frontiers in immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Joseph M LadowskiDepartment of Surgery, University of Alabama at Birmingham, Birmingham AL.
Luz M ReyesDepartment of Surgery, University of Alabama at Birmingham, Birmingham AL.
Gregory R MartensDepartment of Surgery, University of Alabama at Birmingham, Birmingham AL.
James R ButlerDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN.
Zheng-Yu WangDepartment of Surgery, University of Alabama at Birmingham, Birmingham AL.
Devin E EckhoffDepartment of Surgery, University of Alabama at Birmingham, Birmingham AL.
Matthew TectorDepartment of Surgery, University of Alabama at Birmingham, Birmingham AL.
A Joseph TectorDepartment of Surgery, University of Alabama at Birmingham, Birmingham AL.
Indiana University – Purdue University Indianapolis · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008361 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YACOUBIAN, TALENE ALENE · 1992 to 2024
$16.8M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
Optimizing Strategies to Overcome Kidney Xenograft RejectionR01AI126322 · NIAID · UNIVERSITY OF MINNESOTA · PI ADAMS, ANDREW B, TECTOR, A JOSEPH · 2016 to 2020
$4.6M
NIAID NIH HHS P30 AI027767NIAID NIH HHS R01 AI126322NIAMS NIH HHS P30 AR048311NIGMS NIH HHS T32 GM008361
6 · The paper itself

Abstract

backgroundOver 130 000 patients in the United States alone need a lifesaving organ transplant. Genetically modified porcine organs could resolve the donor organ shortage, but human xenoreactive antibodies destroy pig cells and are the major barrier to clinical application of xenotransplantation. The objective of this study was to determine whether waitlisted patients possess preformed antibodies to swine leukocyte antigen (SLA) class II, homologs of the class II HLA.

methodsSera from people currently awaiting solid organ transplant were tested for IgG binding to class II SLA proteins when expressed on mammalian cells. Pig fibroblasts were made positive by transfection with the class II transactivator. As a second expression system, transgenes encoding the alpha and beta chains of class II SLA were transfected into human embryonic kidney cells.

resultsHuman sera containing IgG specific for class II HLA molecules exhibited greater binding to class II SLA positive cells than to SLA negative cells. Sera lacking antibodies against class II HLA showed no change in binding regardless of the presence of class II SLA. These antibodies could recognize either SLA-DR or SLA-DQ complexes.

conclusionsClass II SLA proteins may behave as xenoantigens for people with humoral immunity toward class II HLA molecules.

Indexed as

AnimalsAntigens, HeterophileHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumansImmunoglobulin GSwineAntigens, HeterophileHistocompatibility Antigens Class IHistocompatibility Antigens Class IIImmunoglobulin Gswine leukocyte antigen

Identifiers

PMID28846555
PMCPMC5978411
OpenAlexW2749950263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.